You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Beta-Amyloid

Showing 1 - 25 of 3,835
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

[18F]Florbetazine for Beta Amyloid PET Imaging in Alzheimer's

Recruiting
  • Alzheimer's Disease
  • Beijing, China
    Department of Nuclear Medicine, Peking Union Medical College Hop
Nov 19, 2023

Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease

Recruiting
  • Alzheimer Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 7, 2023

Mild Cognitive Impairment Trial in San Francisco (Transcranial alternating current stimulation)

Completed
  • Mild Cognitive Impairment
  • Transcranial alternating current stimulation
  • San Francisco, California
    University of California, San Francisco
Aug 2, 2022

Insomnia Trial in Kansas City (Cognitive Behavioral Therapy for Insomnia (CBT-I), Sleep and Lifestyle Education)

Recruiting
  • Insomnia
  • Cognitive Behavioral Therapy for Insomnia (CBT-I)
  • Sleep and Lifestyle Education
  • Kansas City, Kansas
    University of Kansas Medical Center- Sleep, Health and Wellness
Nov 1, 2022

Alzheimer Trial (ALZN002 (autologous DCs pulsed with E22W mutant peptide)., Placebo)

Not yet recruiting
  • Alzheimer Disease
  • ALZN002 (autologous DCs pulsed with E22W mutant peptide).
  • Placebo
  • (no location specified)
Apr 17, 2023

Alzheimer Trial in Saint Louis (Lemborexant 25 mg, Placebo)

Recruiting
  • Alzheimer Disease
  • Lemborexant 25 mg
  • Placebo
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 16, 2023

Hypertension Trial in Dallas (Standard Care, Intensive Treatment)

Active, not recruiting
  • Hypertension
  • Standard Care
  • Intensive Treatment
  • Dallas, Texas
    UT Southwestern Medical Center
Aug 11, 2022

Bioavailability, Gut Microbiome, Safety Trial in Lubbock (Low curcumin group, High curcumin group)

Not yet recruiting
  • Bioavailability
  • +2 more
  • Low curcumin group
  • High curcumin group
  • Lubbock, Texas
    Texas Tech University Health Sciences Center
Mar 15, 2023

Postoperative Cognitive Dysfunction Trial in San Francisco (Florbetapir F 18 (18F-AV-45), no intervention)

Recruiting
  • Postoperative Cognitive Dysfunction
  • Florbetapir F 18 (18F-AV-45)
  • no intervention
  • San Francisco, California
    San Francisco VA Medical Center
Jul 6, 2021

Normal Physiology Trial run by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) ([18F]florbetaben)

Completed
  • Normal Physiology
  • [18F]florbetaben
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022

Amyloid in Blood and Imaging Related to Dementia

Recruiting
  • Alzheimer Disease
  • Alzheimer Dementia
  • Blood collection, PiB PET/MRI, and cognitive testing
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 30, 2021

Alzheimer's Disease, Prodromal Alzheimer's Disease, Amyloid Plaque Trial in Liverpool, London (Placebo, ACI-24.060 at Dose A,

Recruiting
  • Alzheimer's Disease
  • +4 more
  • Placebo
  • +6 more
  • Liverpool, United Kingdom
  • +1 more
Jul 13, 2022

Alzheimer Trial in United States (AV-1959D, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • AV-1959D
  • Placebo
  • Phoenix, Arizona
  • +5 more
Dec 22, 2022

Predicting Cognitive Decline From Androgen Deprivation Therapy

Not yet recruiting
  • Prostate Cancer
  • Blood-based assay
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Apr 20, 2023

Alzheimer's Disease Trial in Fuzhou (18F-92)

Recruiting
  • Alzheimer's Disease
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Nov 23, 2021

Alzheimer Trial in Göttingen, Mannheim (TEP)

Completed
  • Alzheimer Disease
  • Göttingen, Germany
  • +1 more
Mar 29, 2022

Alzheimer Trial in New York, Philadelphia (CT1812, Placebo)

Completed
  • Alzheimer Disease
  • New York, New York
  • +1 more
Jan 10, 2022

Alzheimer, Late Onset, Mild Cognitive Impairment, Sleep Trial in Pittsburgh (Time in Bed Restriction, Sleep Schedule)

Recruiting
  • Alzheimer Disease, Late Onset
  • +4 more
  • Time in Bed Restriction
  • Sleep Schedule
  • Pittsburgh, Pennsylvania
    UPMC Western Psychiatric Hospital
Oct 25, 2022

Prognostic Indicators of Response to CSF Shunt in Normotensive

Recruiting
  • Cerebrospinal Fluid Levels of Amyloid Beta 1-42, H-tau and Phospho-tau Proteins
  • +3 more
  • Lumbar CSF protein marker determination
  • Valencia, Spain
  • +1 more
Jun 13, 2023

Alzheimer, Amyloid Beta-Peptides, Risk Assessment Trial in United States (Alzheimer's Disease Risk Disclosure, Amyloid Brain

Active, not recruiting
  • Alzheimer Disease
  • +5 more
  • Alzheimer's Disease Risk Disclosure
  • Amyloid Brain Imaging and Alzheimer's Disease Risk Disclosure
  • Boston, Massachusetts
  • +3 more
Apr 30, 2021

Alcohol Use Disorder Trial in Pittsburgh ([C-11], Pittsburgh Compound B)

Completed
  • Alcohol Use Disorder
  • [C-11]
  • Pittsburgh Compound B
  • Pittsburgh, Pennsylvania
    University of Pittsbyurgh PET Facility
Jul 1, 2020

Alzheimer Trial in Reims (spinal fluid collection)

Completed
  • Alzheimer Disease
  • spinal fluid collection
  • Reims, France
    Chu de Reims
Jun 18, 2020

Obstructive Sleep Apnea, Alzheimer's Disease Trial in New York (Continuous positive airway pressure device)

Completed
  • Obstructive Sleep Apnea
  • Alzheimer's Disease
  • Continuous positive airway pressure device
  • New York, New York
  • +1 more
Jul 23, 2020

Tauopathies Trial in Philadelphia (Amyloid PET scan, Brain MRI Scan, Neurologic exam)

Recruiting
  • Tauopathies
  • Amyloid PET scan
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Oct 14, 2023

Amyloid Beta Protein Trial in Saint Louis, Philadelphia (Escitalopram 20mg for 2 weeks, Escitalopram 20mg for 8 weeks,

Completed
Has Results
  • Amyloid Beta Protein
  • Escitalopram 20mg for 2 weeks
  • +3 more
  • Saint Louis, Missouri
  • +1 more
Apr 6, 2020